Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.
Conceivable Life Sciences has raised $50.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.
Conceivable Life Sciences's investors include Techstars, ACME Capital, Artis Ventures, Black Opal Ventures, Stride.VC.
Conceivable Life Sciences is headquartered in New York, United States.
Conceivable Life Sciences is an AI automation company that offers an automated IVF lab for cell therapies.
Conceivable Life Sciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Conceivable Life Sciences — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/conceivable-life-sciences-new-york-2. Accessed October 21, 2026.
VCBacked. (2025). Conceivable Life Sciences — Funding & Investors. Retrieved October 21, 2026, from https://www.vcbacked.co/company/conceivable-life-sciences-new-york-2
{{cite web |title=Conceivable Life Sciences — Funding & Investors |url=https://www.vcbacked.co/company/conceivable-life-sciences-new-york-2 |website=VCBacked |access-date=October 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated